ChemicalBook > CAS DataBase List > incb057643
incb057643
- Product Name
- incb057643
- CAS No.
- 1820889-23-3
- Chemical Name
- incb057643
- Synonyms
- INCB;CS-2906;incb057643;INCB-057643, 10 mM in DMSO;INCB057643,Apoptosis,Epigenetic Reader Domain,inhibit,INCB 057643,INCB-057643,Inhibitor;2H-1,4-Benzoxazin-3(4H)-one, 8-(6,7-dihydro-6-methyl-7-oxo-1H-pyrrolo[2,3-c]pyridin-4-yl)-2,2,4-trimethyl-6-(methylsulfonyl)-;2,2,4-Trimethyl-8-(6-methyl-7-oxo-6,7-dihydro-1H-pyrrolo[2,3-c]pyridin-4-yl)-6-(methylsulfonyl)-2H-benzo[b][1,4]oxazin-3(4H)-one
- CBNumber
- CB04661175
- Molecular Formula
- C20H21N3O5S
- Formula Weight
- 415.46
- MOL File
- 1820889-23-3.mol
More
Less
incb057643 Property
- Boiling point:
- 787.7±60.0 °C(Predicted)
- Density
- 1.370±0.06 g/cm3(Predicted)
- storage temp.
- Store at -20°C
- solubility
- DMF: 30 mg/ml; DMSO: 30 mg/ml; DMSO:PBS (pH 7.2) (1:6): 0.14 mg/ml
- form
- A crystalline solid
- pka
- 14.74±0.40(Predicted)
- color
- White to off-white
More
Less
N-Bromosuccinimide Price
ChemScene
- Product number
- CS-0042192
- Product name
- INCB-057643
- Purity
- 98.91%
- Packaging
- 5mg
- Price
- $220
- Updated
- 2021/12/16
ChemScene
- Product number
- CS-0042192
- Product name
- INCB-057643
- Purity
- 98.91%
- Packaging
- 10mg
- Price
- $350
- Updated
- 2021/12/16
Biorbyt Ltd
- Product number
- orb573362
- Product name
- INCB057643
- Purity
- >98%
- Packaging
- 100mg
- Price
- $986
- Updated
- 2021/12/16
ChemScene
- Product number
- CS-0042192
- Product name
- INCB-057643
- Purity
- 98.91%
- Packaging
- 50mg
- Price
- $1200
- Updated
- 2021/12/16
Biorbyt Ltd
- Product number
- orb573362
- Product name
- INCB057643
- Purity
- >98%
- Packaging
- 250mg
- Price
- $1949.9
- Updated
- 2021/12/16
More
Less
incb057643 Chemical Properties,Usage,Production
Uses
INCB-057643, is a novel, orally bioavailable BET inhibitor.
in vivo
Production of several cytokines, including IL-6, IL-10 and MIP-1α, is repressed by INCB-057643 in human and mouse whole blood stimulated ex vivo with LPS. Oral administration of INCB-057643 results in significant anti-tumor efficacy in xenograft models of AML, myeloma, and DLBCL. Additionally, combining INCB-057643 with standard of care agents used for the treatment of DLBCL including rituximab and bendamustine results in enhanced anti-tumor efficacy relative to that achieved with single agent therapies at doses that are well tolerated[1].
incb057643 Preparation Products And Raw materials
Raw materials
Preparation Products
More
Less
incb057643 Suppliers
- Tel
- 18149758185
- sales-cpd@caerulumpharma.com
- Country
- China
- ProdList
- 3506
- Advantage
- 58
- Tel
- 021-52996696，15000506266 15000506266
- Fax
- +86-21-52996696
- Country
- China
- ProdList
- 4757
- Advantage
- 55
- Tel
- 021-61312847; 18021002903
- Fax
- QQ:3008007432
- 3008007409@qq.com
- Country
- China
- ProdList
- 71826
- Advantage
- 60
- Tel
- 0-2022843681 15618226720
- Fax
- +86-21-51601218
- chaolaichem@foxmail.com
- Country
- China
- ProdList
- 12475
- Advantage
- 58
- Tel
- 010-50973130 18101056239
- 3193328036@qq.com
- Country
- China
- ProdList
- 29760
- Advantage
- 68
- Tel
- 0550-5196001 15000891977
- Fax
- 0550-5196001
- wj520wjxby@126.com
- Country
- China
- ProdList
- 1944
- Advantage
- 55
- Tel
- 13761310616
- Fax
- QQ: 39324283
- 39324283@qq.com
- Country
- China
- ProdList
- 1637
- Advantage
- 58
- Tel
- 021-58111628 15800915896
- Fax
- QQ 3285589261
- sales@twochem.com
- Country
- China
- ProdList
- 1788
- Advantage
- 58
- Tel
- 021-34625901 18018851262;
- 420970979@qq.com
- Country
- China
- ProdList
- 5894
- Advantage
- 58
- Tel
- 021-000000 13917643586;
- admin@jingshipharmatech.com
- Country
- China
- ProdList
- 9856
- Advantage
- 58